SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001962738-24-000034
Filing Date
2024-06-27
Accepted
2024-06-27 07:28:56
Documents
3
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240627x6k.htm 6-K 17997
2 EX-99 tmb-20240627xex99.htm EX-99 15651
3 GRAPHIC tmb-20240627xex99001.jpg GRAPHIC 9897
  Complete submission text file 0001962738-24-000034.txt   48722
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41666 | Film No.: 241075377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)